| Authors: |
Lee HJ; MD Anderson Cancer Center, Houston, TX., Ramchandren R; University of Tennessee Medical Center, Knoxville, TN., Friedman J; Florida Cancer Specialists and Research Institute, Palm Springs, FL., Melear J; US Oncology Research, The Woodlands, TX., Flinn IW; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN., Burke JM; US Oncology Research, The Woodlands, TX., Linhares Y; Miami Cancer Institute, Baptist Health South Florida, Miami, FL., Gonzales P; Brooke Army Medical Center, Fort Sam Houston, TX., Peterson M; Uvalde Memorial Hospital, Uvalde, TX., Raval M; US Oncology Research, The Woodlands, TX., Chintapatla R; Kadlec Clinic, Kennewick, WA., Feldman TA; John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, NJ., Yimer H; US Oncology Research, The Woodlands, TX., Islas-Ohlmayer M; US Oncology Research, The Woodlands, TX.; Oncology Hematology Care, Cincinnati, OH., Patel A; Oncology Hematology Care, Cincinnati, OH., Metheny L; University Hospitals Cleveland Medical Center, Cleveland, OH., Dean A; US Oncology Research, The Woodlands, TX., Rana V; University of Colorado Health Hematology and Oncology, Colorado Springs, CO., Gandhi MD; US Oncology Research, The Woodlands, TX., Renshaw J; US Oncology Research, The Woodlands, TX., Ho L; Pfizer Inc, Bothell, WA., Fanale MA; Pfizer Inc, Bothell, WA., Guo W; Pfizer Inc, Bothell, WA., Yasenchak CA; Willamette Valley Cancer Institute and Research Center, Eugene, OR. |